share_log

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

SEC ·  Nov 21 05:33

Summary by Futu AI

Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
Charles Faith L., reported a significant acquisition of shares in Conduit Pharmaceuticals (CDT.US) on November 18, 2024. The transaction involved the purchase of 75,000 shares of common stock, followed by an additional 266,594 shares at a price of $0.0919 per share. Following these transactions, Charles Faith L. now directly holds a total of 341,594 shares in the company. The transactions were classified as grants, awards, or other acquisitions, and have been completed as of the reported date.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated